Inducible nitric oxide synthase messenger RNA levels in hip periprosthetic tissue: a preliminary study.
Nitric oxide (NO) is a ubiquitous molecule that has been associated with inflammation, arthritis, autoimmune disease, bone resorption, and other biological processes. Elucidating the role of NO at the bone-implant interface may further our understanding of the biological processes of osseointegration, loosening, and osteolysis. This study demonstrates the use of a molecular biological technique to investigate the possible role of NO in prosthetic loosening and periprosthetic bone resorption following total hip arthroplasty. Periprosthetic tissue from 12 patients undergoing revision hip arthroplasty was harvested and total ribonucleic acid (RNA) was extracted. In six of the 12 patients, multiple samples from different anatomic locations along the same interface were studied. To estimate the amount of NO present in the tissues in vivo, the level of inducible NO synthase (iNOS) messenger RNA (mRNA) was determined using a ribonuclease (RNase) protection assay. Inducible NOS mRNA was detected in every tissue sample: there was no correlation between iNOS mRNA levels and clinical loosening or osteolysis. Analysis of multiple tissue samples from the same prosthetic component revealed that the levels of iNOS mRNA vary greatly, confirming the heterogeneous nature of the interface.
Pearson
M L
ML
Division of Orthopaedic Surgery, Stanford University Medical Center, California 94305, USA.
Goodman
S B
SB
Huie
P
P
Sibley
R K
RK
D000328:Adult; D000368:Aged; D019644:Arthroplasty, Replacement, Hip; D001862:Bone Resorption / Q000503:physiopathology*; D006801:Humans; D008566:Membranes / Q000378:metabolism; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000235:genetics*; D052247:Nitric Oxide Synthase Type II; D010014:Osteolysis / Q000503:physiopathology; D012333:RNA, Messenger / Q000096:biosynthesis*
D012333:RNA, Messenger; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II